|Day Low/High||34.90 / 36.80|
|52 Wk Low/High||13.14 / 58.76|
Two trades I'm making (and one on my radar) as a I stay focused on the price action.
I've previously discussed why these six stocks are my top picks for 2020. I will periodically provide updates and discuss my strategy for trading them.
Here are my takes on stocks in biotech and other companies I own right now.
Many traders don't realize how the nature of price action has shifted.
Given broader market weakness, this is a good time to take a look at these names and develop strategies.
As long as these charts hold up, I will continue to hold them regardless of what the indices might do.
My approach to this sort of action is to forget the indices and focus on managing your individual positions.
It is highly unlikely that the indices are going to roll over and go straight down from here.
A solid fourth-quarter report could bring momentum players back to this Israeli company with great growth potential.
I'm far more excited about the potential buys that I see this action creating than I am about the weakness.
This continues to be a very healthy market that can handle whatever is thrown at it right now.
Here are seven factors the market can be thankful for as the holiday week kicks off.
I will be looking at some index shorts should the selling pressure continue into the afternoon.
Whether you see the indexes trading flat on Monday afternoon as good or bad depends on your outlook.
Let's check out the charts of this medical technologies company.
At some point the market's inconsistency will resolve itself either way.
Even the bulls are anticipating some sort of rest or pullback at this point.
Investors must understand that the narrative around trade with China has evolved as the two sides work on a 'Phase One' mini-trade deal, but this is about much more than that.
I'm still very optimistic about some good entry points but discipline is the key.
The fact that the indices are so buoyant on the job news is an illustration of how much skepticism and fear there is.
This looks like a normal pause within an uptrend.
While the majority of other IPOs have struggled, this stock is in a position to test recent highs.
Checking on the charts of InMode and BioLife Solutions.